908 Devices Inc. (MASS)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
908 Devices Inc. (MASS) Q3 2025 Earnings Call Transcript
908 Devices Inc. ( MASS ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Barbara Russo - VP of Marketing & Corporate Communications Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Brendan Smith - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the 908 Devices Third Quarter 2025 Financial Results Conference Call.
Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains?
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
908 Devices Inc. (MASS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has 908 Devices Inc. ever had a stock split?
908 Devices Inc. Profile
| Technology Hardware, Storage & Peripherals Industry | Information Technology Sector | Kevin J. Knopp CEO | NASDAQ (NMS) Exchange | 65443P102 CUSIP |
| US Country | 246 Employees | - Last Dividend | - Last Split | 18 Dec 2020 IPO Date |
Overview
908 Devices Inc. is a commercial-stage technology company that specializes in providing handheld and desktop mass spectrometry devices designed for a broad range of applications. The company focuses on developing tools for the analysis of unknown and invisible materials across various sectors, including life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Established in 2012 and headquartered in Boston, Massachusetts, 908 Devices offers its cutting-edge analytical tools to customers not only in the United States but also in Europe, the Middle East, Africa, the Asia Pacific, and the rest of the Americas.
Products and Services
-
MX908:
This product is a portable, battery-powered mass spectrometry (Mass Spec) device designed for the swift analysis of solid, liquid, vapor, and aerosol materials. Its handheld form factor makes it especially useful in environments where rapid, on-the-spot analysis of unknown substances is critical.
-
Rebel:
Rebel serves as a compact desktop analyzer that delivers real-time insights into the extracellular environment of bioprocesses. It’s engineered for users who need to monitor the biochemical and physical properties of cell culture media in bioprocessing applications.
-
Maverick:
This optical in-line analyzer is aimed at real-time monitoring and control of multiple parameters in mammalian cell cultures, such as glucose, lactate, and total biomass. Maverick also provides process fingerprint data, which can be instrumental in supporting predictive bioprocess modeling on a large scale.
-
Maven and Trace C2:
An online device designed for bioprocess monitoring and control, catering to the needs of bioengineering professionals requiring accurate, real-time data to ensure the optimal conditions of their bioprocesses.
-
ZipChip:
ZipChip is an innovative, plug-and-play, high-resolution separation platform that enhances Mass Spec sample analysis efficiency. It’s intended for users seeking to optimize their mass spectrometry workflows with a high-throughput, easy-to-integrate solution.
Contact Information
